# Marine Omega-3 Polyunsaturated Fatty Acid, Gut Microbiome, and Colorectal Cancer Prevention

> **NIH NIH R00** · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · 2020 · $247,809

## Abstract

Fish oil, a rich source of marine omega-3 polyunsaturated fatty acids (MO3PUFAs), is the most popular
natural product used by U.S. adults. Substantial data support the beneficial effect of MO3PUFAs on colorectal
cancer (CRC) prevention and treatment. However, the specific mechanisms through which MO3PUFAs
influence CRC are not well understood. Increasing evidence supports a pivotal role of gut microbes in
integrating dietary cues with host immunity and potentially mediating the anticancer effect of MO3PUFAs.
Dietary fat composition is a major driver of the gut microbial community structure. Mice fed with a high-
MO3PUFA diet demonstrate increased abundance of the gut bacteria that support the host immunoprotective
system and improve the efficacy of cancer immunotherapy, such as Bifidobacterium and Lactobacillus
genera, and decreased abundance of the microbes that dampen antitumor immunity, such as Fusobacterium
nucleatum, which has been shown to promote CRC by generating a tumor-permissive microenvironment.
Taken together with my recent findings that the anti-CRC effect of MO3PUFAs is related to F. nucleatum
abundance and immune infiltrates in tumor tissue, these data aggregately support the hypothesis that
MO3PUFAs modulate the gut microbial composition and function to shape the gut immune response and
suppress CRC. To test this hypothesis, I will perform a randomized controlled trial (RCT) in patients with prior
adenoma by investigating the effect of MO3PUFA supplements on the gut microbiome, metabolome, and
gene expression profiling in the colon. This innovative project will advance our understanding about the
interplay between MO3PUFAs, gut microbiota, and host immunity in CRC. I am well suited to perform this
research based on 1) my expertise in nutrition, epidemiology, quantitative methods, and biomarker research;
2) acquired training in the K99 phase on the gut microbiome, bioinformatics, and design and conduct of
biomarker-based RCT; and 3) the unparalleled research environment to support my career development.
Through this study, I will expand my expertise and develop a transdisciplinary research program as an
independent investigator in the area of nutritional intervention, gut microbiome, and cancer prevention. The
findings yielded from my research will uncover new biological mechanisms relating diet to carcinogenesis,
and identify novel biomarkers or targets that can be effectively translated into the clinic to improve cancer
prevention.

## Key facts

- **NIH application ID:** 9983631
- **Project number:** 5R00CA215314-04
- **Recipient organization:** HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH
- **Principal Investigator:** Mingyang Song
- **Activity code:** R00 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $247,809
- **Award type:** 5
- **Project period:** 2018-02-19 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9983631

## Citation

> US National Institutes of Health, RePORTER application 9983631, Marine Omega-3 Polyunsaturated Fatty Acid, Gut Microbiome, and Colorectal Cancer Prevention (5R00CA215314-04). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/9983631. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*